Loading...
XSHE
002872
Market cap167mUSD
Apr 11, Last price  
3.85CNY
1D
0.79%
1Q
-0.26%
IPO
-83.47%
Name

Tiansheng Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002872 chart
No data to show
P/E
—
P/S
2.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
5.14%
Rev. gr., 5y
-23.22%
Revenues
579m
-4.56%
1,004,120,0191,421,960,0591,663,784,3431,843,015,2802,086,931,5572,261,414,3762,171,439,9231,678,052,4661,202,746,111736,685,771606,992,213579,334,659
Net income
-93m
109,987,794125,948,051164,573,145191,977,863224,496,958248,575,37615,621,1870000-93,073,691
CFO
-25m
L
145,057,10057,059,300191,988,710213,538,862506,677,2400153,986,687144,208,286189,754,32918,971,79289,184,806-24,561,761
Dividend
Aug 22, 20180.236 CNY/sh
Earnings
May 16, 2025

Profile

Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
URL
https://www.tszy.com.cn/
IPO date
May 19, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
579,335
-4.56%
606,992
-17.61%
Cost of revenue
566,527
600,911
Unusual Expense (Income)
NOPBT
12,808
6,081
NOPBT Margin
2.21%
1.00%
Operating Taxes
(1,011)
7,437
Tax Rate
122.31%
NOPAT
13,818
(1,356)
Net income
(93,074)
 
Dividends
(15,537)
Dividend yield
0.95%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
200,318
236,349
Long-term debt
67,094
35,534
Deferred revenue
127,794
126,338
Other long-term liabilities
66,178
67,250
Net debt
22,001
(127,120)
Cash flow
Cash from operating activities
(24,562)
89,185
CAPEX
(76,738)
Cash from investing activities
(82,080)
Cash from financing activities
(11,204)
FCF
17,166
16,350
Balance
Cash
192,712
278,250
Long term investments
52,700
120,754
Excess cash
216,445
368,654
Stockholders' equity
553,161
786,813
Invested Capital
2,335,763
2,259,089
ROIC
0.60%
ROCE
0.50%
0.23%
EV
Common stock shares outstanding
318,000
318,000
Price
5.13
-2.84%
5.28
1.15%
Market cap
1,631,340
-2.84%
1,679,040
1.15%
EV
1,657,518
1,556,736
EBITDA
120,067
113,803
EV/EBITDA
13.80
13.68
Interest
14,994
15,784
Interest/NOPBT
117.07%
259.57%